MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$33,228K
EPS
-$0.95
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
Research and development
25,644
33,955
General and administrative
9,293
18,856
Total operating expenses
34,937
52,811
Loss from operations
-34,937
-52,811
Interest income
1,564
2,328
Other expense, net
-1
-1
Total other income (expense), net
1,563
2,327
Loss before income taxes
-33,374
-
Net loss
-33,374
-50,484
Unrealized gain (loss) on available-for-sale securities
146
-122
Comprehensive loss
-33,228
-50,606
Basic EPS
-0.95
-
Diluted EPS
-0.95
-
Basic Average Shares
35,003,000
-
Diluted Average Shares
35,003,000
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$33,228K
Unrealized gain (loss) on
available-for-sale securities
$146K
Net loss
-$33,374K
Interest income
$1,564K
Loss before income
taxes
-$33,374K
Total other income
(expense), net
$1,563K
Other expense, net
-$1K
Loss from operations
-$34,937K
Total operating
expenses
$34,937K
Research and development
$25,644K
General and
administrative
$9,293K
Buy us a coffee
First Tracks Biotherapeutics, Inc. (TRAX)
First Tracks Biotherapeutics, Inc. (TRAX)